# Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE

Study · id `cardio:ct-nct06009588` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06009588](<https://clinicaltrials.gov/study/NCT06009588>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06009588

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06009588. Randomized; double masking; primary purpose treatment. Start 2023-08-31 (actual); primary completion 2026-08-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06009588, source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)
- Started: 2023-08-31 (actual) (ClinicalTrials.gov record NCT06009588, source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)
- Primary completion: 2026-08-30 (anticipated) (ClinicalTrials.gov record NCT06009588, source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)
- Completion: 2026-08-30 (anticipated) (ClinicalTrials.gov record NCT06009588, source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06009588, source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06009588-2024-08-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
- Condition: Aortic Stenosis
- Condition: Ascending Aortic Dilatation
- Intervention (Device): self-expandable valves
- Intervention (Device): balloon-expandable valves
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)

## Provenance

Content hash: 0585fdff67232aaad26e408436620a9c8b2fc799605e8bd268e9915b9516c900
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
